Cholesterol 7-␣-hydroxylase (CYP7A1) is the key enzyme that commits cholesterol to the neutral bile acid biosynthesis pathway and is highly regulated. In the current studies, we have uncovered a role for the transcriptional co-activator PGC-1␣ in CYP7A1 gene transcription. PGC-1␣ plays a vital role in adaptive thermogenesis in brown adipose tissue and stimulates genes important to mitochondrial function and oxidative metabolism. It is also involved in the activation of hepatic gluconeogenesic gene expression during fasting. Because the mRNA for CYP7A1 was also induced in mouse liver by fasting, we reasoned that PGC-1␣ might be an important co-activator for CYP7A1. Here we show that PGC-1␣ and CYP7A1 are also co-induced in livers of mice in response to streptozotocin induced diabetes. Additionally, infection of cultured HepG2 cells with a recombinant adenovirus expressing PGC-1␣ directly activates CYP7A1 gene expression and increases bile acid biosynthesis as well. Furthermore, we show that PGC-1␣ activates the CYP7A1 promoter directly in transient transfection assays in cultured cells. Thus, PGC-1␣ is a key activator of CYP7A1 and bile acid biosynthesis and is likely responsible for the fasting and diabetes dependent induction of CYP7A1. PGC-1␣ has already been shown to be a critical activator of several other oxidative processes including adaptive thermogenesis and fatty acid oxidation. Our studies provide further evidence of the fundamental role played by PGC-1␣ in oxidative metabolism and define PGC-1␣ as a link between diabetes and bile acid metabolism.
The CYP7A11 enzyme converts cholesterol into 7-␣-hydroxycholesterol, which is the first specific intermediate in the neutral bile acid biosynthesis pathway in the liver (1). This is a crucial enzyme in mammalian cholesterol metabolism as diversion into the bile acid pathway is the main route for eliminating excess cholesterol from the body. Because of its key role in cholesterol metabolism, the CYP7A1 enzyme and its gene have been studied as an important model for dietary regulation for several years. These studies have revealed that there is a significant amount of regulation at the level of transcription initiation (2); however, post-transcriptional mechanisms for control also occur (1, 3).The CYP7A1 promoter has been extensively evaluated by several groups and the proximal regions of both the mouse and rat promoters contain two direct repeat type elements that bind several nuclear receptors, some of which are indicated in Fig. 1. There is also a binding site for the monomeric orphan receptor LRH-1 that overlaps the DR-1 element. The DR-4 is a target site for the nuclear receptor LXR, which confers positive regulation by cholesterol to the CYP7A1 promoter in mice and rats (2). However, the DR-4 is not conserved in the human gene which is not subject to feed forward regulation by cholesterol (4).CYP7A1 is also activated in livers of fasted mice (5). Similarly, the transcriptional co-activator PGC-1␣ is induced by fasting in liver where it activates transcrip...